Press Releases from Kwizda Pharma GmbH (2 total)
BIOSIMILAR G-CSF: COOPERATION ON THREE CONTINENTS
A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada…
NEUTROPENIA: BIOSIMILAR PRODUCT FROM INDIA MOVES ONE STEP CLOSER TO EUROPEAN MAR …
A biosimilar product for treating the negative effects that cancer chemotherapy can have on the white blood cells of patients is safe and exhibits an…
Go To Page:
